A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokines
- 1 January 1986
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 16 (9) , 1143-1149
- https://doi.org/10.1002/eji.1830160919
Abstract
Monocytes from moderately eosinophilic individuals secrete material that enhances the cytotoxic activity of eosinophils against antibody‐coated schistosomula of Schistosoma mansoni. This material is not a single substance, but can be fractionated into several active components of different size and different charge. Gel filtration of mononuclear cell supematants separated the eosinophil‐activating activity into a major component of molecular mass of 40 kDa and a minor component of molecular mass of < 10 kDa. The major component exhibited further heterogeneity on fractionation by high performance liquid chromatography. The bulk of the eosinophil‐activating activity could be separated from both colony‐stimulating factor (CSF)α activity and from tumor necrosis factor (TNF) activity. However, human recombinant CSFα (GM‐CSF), human recombinant TNF and rabbit tumor necrosis serum all had eosinophil‐activating activity when tested against schistosomula. Eosinophils were not activated by interleukin 1, interleukin 2, interferon‐α, lipopolysaccharide or phorbol myristate acetate.This publication has 38 references indexed in Scilit:
- Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.Proceedings of the National Academy of Sciences, 1986
- Activation of human eosinophils by monokines and lymphokines: Source and biochemical characteristics of the eosinophil cytotoxicity-enhancing activity produced by blood mononuclear cellsCellular Immunology, 1985
- Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cellsNature, 1985
- Partial purification and biological properties of an eosinophil-activating factorEuropean Journal of Immunology, 1985
- Eosinophil-mediated killing of schistosomula of Schistosoma mansoni: Oxidative requirement for enhancement by eosinophil colony stimulating factor (CSF-α) and supernatants with eosinophil cytotoxicity enhancing activity (E-CEA)Cellular Immunology, 1984
- Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic Schistosomiasis mansoniCellular Immunology, 1984
- Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro.The Journal of Experimental Medicine, 1983
- Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s).The Journal of Experimental Medicine, 1982
- Separation of functionally distinct human granulocyte-macrophage colony- stimulating factorsBlood, 1979
- Preparation of colony stimulating factors from human placental conditioned mediumLeukemia Research, 1978